Taiwan’s Caliway Biopharmaceuticals Co. Ltd. said it secured more than $100 million in an oversubscribed capital raise to advance CBL-514, its lead asset for subcutaneous fat reduction nearing phase III studies.

Med-tech firms raising money in public or private financings, including: Biorithm, Luma.

Biopharmas raising money in public or private financings, including: Betterlife, Biora, Eterna, Pivotal Life.

Biopharmas raising money in public or private financings, including: AC Immune, Awakn, Eterna, Fractyl, Syndax, Totus.

Deep Apple Therapeutics Inc., a portfolio company created and incubated by Apple Tree Partners, has raised $52 million in series A round.

Biopharmas raising money in public or private financings, including: Amazentis, Cadenza, Ocular, Vandria, Veru.

Carthera SA received an additional €4.5 million (US$4.9 million) from investors to take its series B funding round to €42 million despite a tough fundraising environment for med-tech companies. Frédéric Sottilini, CEO of Carthera, told BioWorld that the strong investor interest was testament to their confidence in the company’s Sonocloud technology for brain disorder treatment.

Vandria SA has announced a series A financing round raising $20.6 million (CHF18 million) to help advance its pipeline of first-in-class small-molecule mitophagy inducers.